Home › Funds › Citigroup Inc › GRDN
Citigroup Inc position in GRDN
GUARDIAN PHARMACY SVCS INC · Consumer Staples
Latest position (Q2 2026)15.52K sh
Reported value held$649.61K
Portfolio Weight0.00%
First reportedQ4 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 6.74K | $136.49K | New |
| Q1 2025 | 6.03K | $128.11K | Reduce |
| Q2 2025 | 5.45K | $116.22K | Reduce |
| Q3 2025 | 2.42K | $63.48K | Reduce |
| Q4 2025 | 11.68K | $351.36K | Add |
| Q1 2026 | 3.33K | $125.60K | Reduce |
| Q2 2026 | 15.52K | $649.61K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GRDN
- Fidelity Management & Research (FMR) 3.24M sh · $135.73M · Q2 2026
- Wellington Management Group 1.73M sh · $72.39M · Q2 2026
- BlackRock Inc 1.58M sh · $65.99M · Q2 2026
- Vanguard Group 1.35M sh · $40.73M · Q4 2025
- Franklin Resources 966.21K sh · $40.46M · Q2 2026
- Geode Capital Management 646.70K sh · $27.08M · Q2 2026
- Morgan Stanley 312.00K sh · $13.06M · Q2 2026
- Northern Trust Corp 211.38K sh · $8.85M · Q2 2026
- Goldman Sachs Group 171.69K sh · $7.19M · Q2 2026
- Lazard Asset Management 169.53K sh · $7.10M · Q2 2026
- Bank of America Corp 163.17K sh · $6.83M · Q2 2026
- Millennium Management 120.61K sh · $5.05M · Q2 2026